Navigation Links
Ovarian Cancer Prognosis May Depend on Gene Mutations

MONDAY, April 4 (HealthDay News) -- Ovarian cancer patients with the BRCA2 gene mutation are more likely to survive than those with the BRCA1 mutation or patients without either mutation, a new study finds.

U.S. researchers analyzed 3,531 cases of epithelial ovarian cancer, including 1,178 patients with BRCA1 mutations, 367 with BRCA2 mutations and 1,986 with neither mutation.

Five-year survival rates were 61 percent for those with the BRCA2 mutation, 46 percent for those with the BRCA1 mutation and 36 percent for those with neither mutation, the investigators found.

The study is to be presented Monday at the annual meeting of the American Association for Cancer Research, in Orlando, Fla. The research is considered preliminary until it is published in a peer-reviewed journal.

"There was some previous evidence that women with ovarian cancer who have mutations in the BRCA genes show improved survival compared to non-mutation carriers. Our study clearly shows that this survival difference is real. We also provide the first solid evidence that BRCA1 and BRCA2 mutations don't have the same impact on ovarian cancer survival," Kelly Bolton, a fellow at the U.S. National Cancer Institute, said in an AACR news release.

Further research is needed to find out why BRCA2 mutations are associated with better survival than BRCA1 mutations or no mutations. The mutations may affect a patient's response to chemotherapy, Bolton suggested.

About 1 in 400 to 1 in 800 women are born with either the BRCA1 or BRCA2 mutations, which increase the risk of ovarian and breast cancer. About 5 percent of ovarian cancer patients have BRCA1 or BRCA2 mutations.

More information

The American Cancer Society has more about ovarian cancer.

-- Robert Preidt

SOURCE: American Association for Cancer Research, news release, April 4, 2011

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Philanthropic pledge triples funds for TGen ovarian cancer research
2. Ohio State study: Targeted ovarian cancer therapy not cost-effective
3. GPs take more than a month to record ovarian cancer diagnosis in one in 10 cases
4. Nearly 25% of Women With Early Ovarian Cancer Not Given Recommended Biopsies
5. New clinical trial to determine ovarian cancer risks in African-American women
6. Ovarian Cyst Syndrome May Raise Health Risks from Plastics Chemical
7. UH biochemist works to revolutionize ovarian cancer treatment
8. Ovarian cancer advances when genes are silenced
9. Few Lives Saved by Ovarian Cancer Screening: Study
10. Biological diversity of ovarian cancer lessens value of screening
11. Researchers map the way to personalised treatment for ovarian cancer
Post Your Comments:
Related Image:
Ovarian Cancer Prognosis May Depend on Gene Mutations
(Date:10/13/2017)... ... 13, 2017 , ... Lori R. Somekh, founder of the Law Office ... of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our office ... forum to network with elder law attorneys nationwide,” said Somekh. , ElderCounsel ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading ... to advocate for action towards gender equality at their inaugural Summit in New York ... globe, and reached a social audience of over 3 million. To watch the Mobilize ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... 2017 , ... The American College of Medical Informatics (ACMI) will present the ... Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... a pioneer in the field of medical informatics, this prestigious award is presented to ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Halo Labs announces the European launch of their new low volume, ... 2017 in Cambridge, U.K on October 4th. ... samples with unprecedented speed and sensitivity while using far less sample ... ... system ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation ... and home sensors for real-time monitoring of patients with ... nonprofit organization focused on disruptive health solutions for rare ... system to record and integrate behavioral, cognitive, physiological and ... ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
Breaking Medicine Technology: